BOOM BOOM2 , Lily, Klip MOU2 - Bank? Who? Some posts are worth a...

First 768 Last

Share
Profile

Follow
Glyco

6,165 Posts.

2345

08/11/17

15:08

Post #: 28609206
Share

Originally posted by mcbr1990 ↑

My speculation on the reduced quarterly numbers was that it was due to Boom2 being trialed by some of our bigger customers i.e Ipac WA and SA etc. The Market update says that Boom2 is practically ready for trialing with new customers and I would think that they would have gone through a beta testing stage with existing customers that they have a strong relationship with.

Due to the nature of Boom2 being AI and the focus on greatly reducing the human input on both customer and IAM's side, I believe the cost per process will also be lower than what we currently offer with the plan of being much more scaleable.

This would be why there was a increase in the number of SOA's ordered but the reduction in revenue. This also partly explains the ambiguous comment "the reduction in revenues collected during the September 2017 quarter reflect the disruptive impact Intiger's services have on financial planning practices".

I think if this is the case it bodes well for IAM as the BOP aspect didn't offer a large enough price difference to encourage companies to take the risk and move there business across, it also was going to be difficult to scale and I don't think the larger customers were confident that I am could handle the load.

I think Lilly fixes a number of these concerns, it will be at a price point that if you don't transition you will be priced out, and secondly due to the automation and speed component its scaleability is suitable for taking on the larger customers.

While the reduction in revenue was disappointing, I think the market update was positive and the market over reacted without looking into the context of where the company is at.

IAM is much more advanced in its development than 12 months ago and by moving to a technology backing of automation and AI vs the BOP wage arbitrage model, revenue can go for 0-100 in a blink, it only takes one big customer.

It is still super high risk at this point but I believe the risk is less than it was 12 months ago and the risk/reward ratio is equally super high. If they manage to kick 1 goal with a bank of large independent we will be many multiples higher.

All in my opinion and only time will tell.

mcbr

Expand

BOOM

BOOM2 , Lily, Klip

MOU2 - Bank? Who?

Some posts are worth a second reading, esp on MOU2.
.
GravyTrain01

s_hancock

and others

Disclosure:

Sold out most sh/op after June17 disappointing, qtrly, >3 months ago.
Buying back again heads, gradually, for a low MCap fintech.
Worth a punt, for specky , like a gold explorer.
*Dec/Jan will be fun to watch, imo.
High risk/reward situation-play
(Trolls are on 'paid leave '?)
Under 5% of portfolio.

*
Aimo. Dyor. Buy-Sell-Hold is your own decision
.................................................................................
'Know what you buy & why you buy'
*

Last edited by Glyco: 08/11/17

IAM Price at posting: 1.3¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 525 more messages in this thread...

First 768 Last

Add CF1 (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change -0.002(9.09%)		Mkt cap ! $11.43M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.0¢	$23.09K	1.116M

Buyers (Bids)

No.	Vol.	Price($)
1	491617	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	200000	1

View Market Depth

No.	Vol.	Price($)
1	491617	0.020
1	2772	0.019
3	1434231	0.018
1	1000000	0.017
1	1000000	0.016

Price($)	Vol.	No.
0.022	200000	1
0.024	125000	1
0.026	64744	1
0.030	827135	4
0.040	100000	1

Last trade - 15.01pm 02/10/2024 (20 minute delay)

CF1 (ASX) Chart

BOOM BOOM2 , Lily, Klip MOU2 - Bank? Who? Some posts are worth a...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

BOOM BOOM2 , Lily, Klip MOU2 - Bank? Who? Some posts are worth a...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News